Radiotherapy Market - Global Forecasts to 2020

The global radiotherapy market is expected to reach USD 7,544.8 million by 2020 from USD 5,585.0 million in 2015, at a CAGR of 6.2% between 2015 and 2020. North America is expected to hold the largest share of the global radiotherapy market in 2015. By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.

Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.

As of 2014, the global radiotherapy market was dominated by Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), and Accuray Incorporated (U.S.), which together held a share of 84.5% of the overall radiotherapy market. New product launches & product enhancements; agreements, collaborations, partnerships, and contracts; geographic expansions; strategic acquisitions; and others (awareness campaigns and offering research fund & grants) are the major strategies adopted by most market players to achieve growth in the global radiotherapy market.


Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the radiotherapy market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on radiotherapy products offered by the top 10 players in the radiotherapy devices market. The report analyzes the radiotherapy market by product, application, and technology

‧ Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the radiotherapy market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various radiotherapy devices across four geographies

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the radiotherapy market

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 22
2.1.2.2 Key data from primary sources 22
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1.1 Bottom-up approach 24
2.2.1.2 Top-down approach 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 RESEARCH ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
3.1 INTRODUCTION 28
3.2 CURRENT SCENARIO 29
3.3 FUTURE OUTLOOK 30
3.4 CONCLUSION 32
4 PREMIUM INSIGHTS 33
4.1 GLOBAL RADIOTHERAPY MARKET (2015–2020) 33
4.2 GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT (2015 VS. 2020) 34
4.3 EXTERNAL BEAM RADIATION THERAPY MARKET, BY TECHNOLOGY (2015 VS. 2020) 35
4.4 GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION (2015) 36
?
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 RADIOTHERAPY MARKET, BY PRODUCT 37
5.2.2 RADIOTHERAPY MARKET, BY TECHNOLOGY 38
5.2.3 RADIOTHERAPY MARKET, BY APPLICATION 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 41
5.3.1.1 Technological advancements 41
5.3.1.2 Growing number of cancer patients 41
5.3.1.3 Rapidly increasing aging population 42
5.3.1.4 Rising adoption of radiotherapy devices and procedures 43
5.3.1.5 Increasing number of symposiums spreading awareness about the benefits of radiotherapy 44
5.3.2 RESTRAINTS 46
5.3.2.1 Lack of adequate infrastructure & healthcare expenditure 46
5.3.2.2 Shortage of trained personnel 46
5.3.2.3 Unfavourable healthcare reforms in the United States 47
5.3.3 OPPORTUNITIES 48
5.3.3.1 Emerging markets offer numerous growth opportunities 48
5.3.3.2 Increasing demand for cancer treatment driving investments in radiotherapy 48
5.3.4 CHALLENGES 49
5.3.4.1 Difficulty in visualizing tumors 49
5.3.4.2 Affordability and accessibility of treatment 50
6 RADIOTHERAPY MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 EXTERNAL BEAM RADIATION THERAPY 53
6.2.1 INTRODUCTION 53
6.2.2 ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS (LINAC) 54
6.2.3 COMPACT ADVANCED RADIOTHERAPY SYSTEMS 55
6.2.3.1 Introduction 55
6.2.3.2 CyberKnife 56
6.2.3.3 Gamma Knife 57
6.2.3.4 TomoTherapy 57
6.2.4 PROTON THERAPY SYSTEMS 58
6.2.4.1 Cyclotron 60
6.2.4.2 Synchrotron 61
6.3 INTERNAL RADIATION THERAPY 62
6.3.1 INTRODUCTION 62
6.3.2 SEEDS 63
6.3.3 APPLICATORS AND AFTERLOADERS 64
6.3.4 ELECTRONIC BRACHYTHERAPY 65
6.4 SYSTEMIC RADIATION THERAPY 66
7 RADIOTHERAPY MARKET, BY TECHNOLOGY 67
7.1 INTRODUCTION 68
7.2 EXTERNAL BEAM RADIATION THERAPY 69
7.2.1 INTRODUCTION 69
7.2.2 IMAGE-GUIDED RADIOTHERAPY (IGRT) 71
7.2.3 INTENSITY MODULATED RADIOTHERAPY (IMRT) 72
7.2.4 STEREOTACTIC TECHNOLOGY 73
7.2.5 PARTICLE/PROTON BEAM THERAPY 74
7.2.6 TOMOTHERAPY 75
7.2.7 3D-CONFORMAL RADIOTHERAPY (3D-CRT) 76
7.2.8 VOLUMETRIC MODULATED ARC THERAPY 77
7.3 INTERNAL BEAM RADIATION THERAPY 78
7.3.1 INTRODUCTION 78
7.3.2 LOW-DOSE RATE RADIOTHERAPY 79
7.3.3 HIGH DOSE RATE RADIOTHERAPY 80
7.4 SYSTEMIC RADIATION THERAPY 81
8 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION 82
8.1 INTRODUCTION 83
8.2 EXTERNAL BEAM RADIATION THERAPY 84
8.2.1 INTRODUCTION 84
8.2.2 PROSTATE CANCER 86
8.2.3 BREAST CANCER 87
8.2.4 LUNG CANCER 88
8.2.5 HEAD AND NECK CANCER 89
8.2.6 COLORECTAL CANCER 90
8.2.7 OTHERS 91
8.3 INTERNAL RADIATION THERAPY/BRACHYTHERAPY 92
8.3.1 INTRODUCTION 92
8.3.2 PROSTATE CANCER 94
8.3.3 GYNECOLOGICAL CANCER 95
8.3.4 BREAST CANCER 96
8.3.5 CERVICAL CANCER 97
8.3.6 PENILE CANCER 98
8.3.7 OTHERS 99
?
9 RADIOTHERAPY MARKET, BY REGION 100
9.1 INTRODUCTION 101
9.2 NORTH AMERICA 103
9.3 EUROPE 109
9.4 ASIA-PACIFIC 115
9.5 REST OF THE WORLD (ROW) 122
9.5.1 LATIN AMERICA 127
9.5.2 MIDDLE EAST 128
9.5.3 AFRICA 129
10 COMPETITIVE LANDSCAPE 130
10.1 OVERVIEW 130
10.2 MARKET SHARE ANALYSIS 131
10.3 COMPETITIVE SITUATION AND TRENDS 133
10.3.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 134
10.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS 135
10.3.3 MERGERS AND ACQUISITIONS 136
10.3.4 GEOGRAPHIC EXPANSIONS 137
10.3.5 OTHER DEVELOPMENTS 138
11 COMPANY PROFILES 139
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 139
11.2 VARIAN MEDICAL SYSTEMS, INC. 140
11.3 ELEKTA AB 146
11.4 ACCURAY INCORPORATED 153
11.5 IBA (ION BEAM APPLICATIONS SA) 156
11.6 NORDION, INC. 160
11.7 C. R. BARD, INC. 162
11.8 ISORAY MEDICAL, INC. 164
11.9 RAYSEARCH LABORATORIES AB 166
11.10 MEVION MEDICAL SYSTEMS, INC. 169
11.11 MITSUBISHI ELECTRIC CORPORATION 171
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 173
12.1 DISCUSSION GUIDE* 173
12.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 177
12.3 AVAILABLE CUSTOMIZATIONS 177
12.4 RELATED REPORTS 178